Open access
Open access
Powered by Google Translator Translator

Prescribing SGLT2 inhibitors in patients with chronic kidney disease: expanding indications and practical considerations.

19 May, 2022 | 10:43h | UTC

Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations – Kidney International Reports

 

Commentary on Twitter

Under a CC BY-NC-ND 4.0 license

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.